Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum Levels of Surfactant Proteins in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE).

PloS one - 1 Jan 2016

Papaioannou Andriana I, Kostikas Konstantinos, Manali Effrosyni D, Papadaki Georgia, Roussou Aneza, Spathis Aris, Mazioti Argyro, Tomos Ioannis, Papanikolaou Ilias, Loukides Stelios, Chainis Kyriakos, Karakitsos Petros, Griese Matthias, Papiris Spyros

Abstract excerpt

INTRODUCTION: Emphysema and idiopathic pulmonary fibrosis (IPF) present either per se or coexist in combined pulmonary fibrosis and emphysema (CPFE). Serum surfactant proteins (SPs) A, B, C and D levels may reflect lung damage. We evaluated serum SP levels in healthy controls, emphysema, IPF, and CPFE patients and their associations to disease severity and survival. METHODS: 122 consecutive patients (31...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fibrosis
Share to Kaplan-Meier Estimate

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Physical Fitness

Share to Pulmonary Emphysema

Share to Pulmonary Fibrosis

Share to Pulmonary Surfactant-Associated Proteins

Share to Respiratory Function Tests

Share to Smoking

Source

Open in PubMed Open full text

Identifiers

PMID: 27337142
DOI: 10.1371/journal.pone.0157789
PMCID: PMC4919090

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum Levels of Surfactant Proteins in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE).PMID 27337142Read ↗

Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis.Semantic proximity Read ↗

Combined Pulmonary Fibrosis and Emphysema: An Experimental and Clinically Relevant PhenotypeSemantic proximity Read ↗

Combined pulmonary fibrosis and emphysema: The many aspects of a cohabitation contract.Semantic proximity Read ↗

Surfactant protein D as a biomarker for chronic obstructive pulmonary disease.Semantic proximity Read ↗

The impact of emphysema in pulmonary fibrosis.Semantic proximity Read ↗

[High-resolution CT imaging phenotypes, clinical characteristics, and prognosis in patients with combined pulmonary fibrosis and emphysema].Semantic proximity Read ↗

Differences in serum SP-D levels between German and Japanese subjects are associated with SFTPD gene polymorphisms.Semantic proximity Read ↗

Immunomodulatory roles of surfactant proteins A and D: implications in lung disease.Semantic proximity Read ↗

Differential Impact of Co-expressed SP-A1/SP-A2 Protein on AM miRNome; Sex DifferencesSemantic proximity Read ↗

Functional polymorphisms in surfactant protein genes and chronic obstructive pulmonary disease risk: a meta-analysis.Semantic proximity Read ↗

Surfactant protein A and B genetic variants predispose to idiopathic pulmonary fibrosis.Semantic proximity Read ↗

Pulmonary function impairment in patients with combined pulmonary fibrosis and emphysema with and without airflow obstruction.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.